Rejuvenation Technologies Inc.

Rejuvenation Technologies Inc. is focused on extending the human health span through innovative telomere extension therapies. Their core technology involves the delivery of TERT mRNA, which has demonstrated the ability to extend telomeres within a few days. This extension is sufficient to reverse the telomere shortening that occurs over a decade during the natural aging process. The company is actively developing and advancing TERT mRNA-based therapies towards clinical applications, with the goal of addressing age-related diseases and promoting overall health and longevity.